Senate Bill Would Boost Oversight Of US FDA User Fee Program Following Trump Reorganization

 
• By Sarah Karlin-Smith
  
person in business suit making "eyes on you" signal with hands.
Senate appropriators plan to keep a much closer eye on FDA user fee program spending in their FY 2026 spending bill. (Shutterstock)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Legislation

More from Policy & Regulation